Exploring the prognostic value of the neutrophil-to-lymphocyte ratio in cancer
Reads0
Chats0
TLDR
NLR may have greater prognostic value in patients with certain demographic and clinical features, after further characterization of populations in which NLR has maximum prognostic potential and the identification of meaningful thresholds for risk stratification.Abstract:
In cancer patients, a high pre-treatment neutrophil-to-lymphocyte ratio (NLR) is associated with poorer survival outcomes. Significant variation in the magnitude of this association has been observed between studies, but sources of this variation are poorly understood. Here, we explore differences in the prognostic potential of NLR between patient subgroups stratified by demographic and clinical characteristics using a retrospective cohort of 5,363 patients treated at Moffitt Cancer Center (Tampa, FL). We identify patients for whom NLR has maximum prognostic potential via adjusted hazard ratios (HRs) calculated using multivariable Cox proportional hazards models and area under the curve analysis. NLR demonstrates stronger associations (HRs > 2) with survival among African-American patients, patients receiving radiation therapy, stage IV patients, and melanoma patients when compared with the overall study population (HR = 1.58). Sensitivity and specificity of NLR as a prognostic marker are also higher in these patient subgroups, and increase further with combinations of multiple “high-risk” demographic or clinical characteristics. In summary, NLR may have greater prognostic value in patients with certain demographic and clinical features. Future prospective studies could validate this hypothesis, after further characterization of populations in which NLR has maximum prognostic potential and the identification of meaningful thresholds for risk stratification.read more
Citations
More filters
Journal ArticleDOI
Systemic immunity in cancer
TL;DR: In this paper, the authors comprehensively outline the current knowledge of systemic immunity in cancer, and show that new immune responses in individuals burdened with tumours are compromised even beyond the TME.
Journal ArticleDOI
Targeting the gut and tumor microbiota in cancer
Elizabeth M. Park,Manoj Chelvanambi,Neal Bhutiani,Guido Kroemer,Laurence Zitvogel,Jennifer A. Wargo +5 more
TL;DR: This Review outlines the current state of research toward harnessing the microbiome to better prevent and treat cancer and outlines key elements of future multidisciplinary and precision-medicine approaches.
Journal ArticleDOI
Predictive value of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in advanced hepatocellular carcinoma patients treated with anti-PD-1 therapy.
Sirish Dharmapuri,Umut Ozbek,Jung-Yi Lin,Max Sung,Myron Schwartz,Andrea D. Branch,Celina Ang +6 more
TL;DR: The relationship between neutrophil‐lymphocyte ratio (NLR) and platelet-lymphocytes ratio (PLR), and survival outcomes, pretreatment and after three doses (posttreatment) of nivolumab in HCC patients is evaluated.
Journal ArticleDOI
The Neutrophil-to-Monocyte Ratio and Lymphocyte-to-Neutrophil Ratio at Admission Predict In-Hospital Mortality in Mexican Patients with Severe SARS-CoV-2 Infection (Covid-19)
Salma A. Rizo-Téllez,Lucia A Méndez-García,Cruz Flores-Rebollo,Fernando Alba-Flores,Raúl Alcántara-Suárez,Aarón N. Manjarrez-Reyna,Neyla Baltazar-López,Verónica A. Hernández-Guzmán,José Israel León-Pedroza,Rogelio Zapata-Arenas,Antonio González-Chávez,Joselín Hernández-Ruiz,José D. Carrillo-Ruiz,Raúl Serrano-Loyola,Guadalupe Mercedes Lucia Guerrero-Avendaño,Galileo Escobedo +15 more
TL;DR: This study demonstrates for the first time that NMR and LNR are accurate predictors of in-hospital mortality at admission in patients with severe Covid-19.
Journal ArticleDOI
The Pan-Immune-Inflammation-Value Predicts the Survival of Patients with Human Epidermal Growth Factor Receptor 2 (HER2)—Positive Advanced Breast Cancer Treated with First-Line Taxane-Trastuzumab-Pertuzumab
Francesca Ligorio,Giovanni Fucà,Emma Zattarin,Riccardo Lobefaro,Luca Zambelli,Rita Leporati,Carmen G. Rea,Gabriella Mariani,Giulia Bianchi,Giuseppe Capri,Filippo de Braud,Claudio Vernieri +11 more
TL;DR: The Pan-Immune-Inflammatory Value (PIV), a recently defined parameter, taking into account peripheral blood neutrophil, platelet, monocyte and lymphocyte counts, is identified as an independent predictor of worse OS in patients with HER2+ aBC receiving first line trastuzumab-pertuzuumab biochemotherapy.
References
More filters
Journal ArticleDOI
Inflammation and cancer
Lisa M. Coussens,Zena Werb +1 more
TL;DR: It is now becoming clear that the tumour microenvironment, which is largely orchestrated by inflammatory cells, is an indispensable participant in the neoplastic process, fostering proliferation, survival and migration.
Journal ArticleDOI
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
Arnoud J. Templeton,Mairéad G McNamara,Bostjan Seruga,Francisco E. Vera-Badillo,Priya Aneja,Alberto Ocaña,Raya Leibowitz-Amit,Guru Sonpavde,Jennifer J. Knox,Ben Tran,Ian F. Tannock,Eitan Amir +11 more
TL;DR: A high NLR is associated with an adverse OS in many solid tumors, and its addition to established prognostic scores for clinical decision making warrants further investigation.
Journal Article
Ratio of neutrophil to lymphocyte counts--rapid and simple parameter of systemic inflammation and stress in critically ill.
TL;DR: In the population of 90 ICU oncological patients, rapid serial changes in white blood cell populations are observed, as a response of the immune system to surgical stress, systemic inflammation or sepsis.
Journal ArticleDOI
IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis.
Seth B. Coffelt,Kelly Kersten,Chris W. Doornebal,Jorieke Weiden,Kim Vrijland,Cheei-Sing Hau,Niels J. M. Verstegen,Metamia Ciampricotti,Lukas J. A. C. Hawinkels,Jos Jonkers,Karin E. de Visser +10 more
TL;DR: It is shown that tumours maximize their chance of metastasizing by evoking a systemic inflammatory cascade in mouse models of spontaneous breast cancer metastasis, and targeting this novel cancer-cell-initiated domino effect within the immune system—the γδ T cell/IL-17/neutrophil axis—represents a new strategy to inhibit metastatic disease.
Journal ArticleDOI
The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancer
Graeme J.K. Guthrie,Kellie A. Charles,Campbell S.D. Roxburgh,Paul G. Horgan,Donald C. McMillan,Stephen Clarke +5 more
TL;DR: The present systematic review examines and comments on the clinical utility of the neutrophil-lymphocyte ratio, which has shown that NLR is elevated in patients with more advanced or aggressive disease evidenced by increased tumour stage, nodal stage, number of metastatic lesions and as such these patients may represent a particularly high-risk patient population.